The Hepatitis C Drug Market To Witness Remarkable Growth And Projected To Make USD 33.50 Billion By 2022

The global hepatitis C drug market has marked a few key active players including Gilead Sciences, Roche, Basel GlaxoSmith, Johnson & Johnson, Kenilworth, Merck & Co, Bristol-Myers Squibb, and AbbVie. These participants are set to strengthen the expansion of the global hepatitis C drug market in the coming period. The Zion Market Research analysts have predicted the global hepatitis C drug market to be valued at around USD 13.50 Billion in 2016 and is anticipated to surpass around USD 33.50 by 2022-end, expanding at a CAGR of approximately 16.0% during 2017–2022.

This review is based on a report by Zion Market Research, titled “Hepatitis C Drug Market for Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”- Report at https://www.zionmarketresearch.com/report/hepatitis-c-drug-market

Hepatitis C Drug Market Growth To Be Majorly Driven By Increase In HCV Prevalence

As per the market analysis, the rise in HCV prevalence all across the world is likely to bolster the growth of the global hepatitis C drug market in the coming period. Further, several lifestyle-related factors, like unsafe sex, transferring of body fluid, and having multiple sex partners are anticipated to drive the hepatitis C drug market growth. Conversely, lack of awareness and information about HCV, treatment cost, and problems associated with regulation & development of drugs may hamper the growth of the hepatitis C drug market. Nonetheless, recent efficient treatments are projected to bring expansion avenues in the hepatitis C market in the coming period. For instance, a new hepatitis C drug was developed by a nonprofit organization, in April 2018, which is just as effectual as those produced by other drug giants, which is likely to boost the hepatitis C drug market growth.

North America Witnessed Growth Owing To Extensive Hospital Accessibility

The hepatitis C drug market is bifurcated on the basis of end-users such as hospitals, private labs, physician offices, blood banks, and public health labs. These sectors are the key end-users of the worldwide hepatitis C drug market. Hospitals were the governing end-user recently in terms of income and the same is projected to be the rapid and largest expanding sector during the forecast period within the hepatitis C drug market.

North America, in terms of regions, was the governing market for the hepatitis C drug market in 2016 in terms of income on account of the extensive ease of access to hospitals. In addition, lifestyle-related factors such as having multiple sex partners and unprotected sex have become very common in North America and European nations. Apart from this, hepatitis C drug has vast growth opportunities in budding regions such as the Asia Pacific and Latin America as a result of the government initiatives, healthcare infrastructure, and increasing digit of people suffering from HCV.

This report segments the global Hepatitis C drug market as follows:

Global Hepatitis C Drug Market:  End-User Analysis

• Hospitals
• Private labs
• Physician offices
• Public health labs
• Blood Bank

Global Hepatitis C Drug Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com